FDA Has Ways to Go to Keep Pace with 2020/21 Approvals

In the first six months of 2022, the U.S. Food and Drug Administration approved only 16 novel drugs. Some of the approvals were supplemental, expanding previous authorizations, while some will likely be game-changers for the treatment of various diseases.